Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16641682 | 1.00 | TSHR (0.66) | TSHREPHX1TDP1MAPTMEN1 | |
| SCHEMBL13171360 | 0.91 | TSHR (0.64) | TSHREPHX1TDP1MAPTMEN1 | |
| SCHEMBL18643015 | 0.91 | TSHR (0.64) | TSHREPHX1TDP1MAPTMEN1 | |
| SCHEMBL13171329 | 0.91 | TSHR (0.80) | TSHREPHX1TDP1MAPTMEN1 | |
| SCHEMBL47727 | 0.89 | TSHR (0.62) | TSHR | |
| SCHEMBL12394889 | 0.88 | TSHR (0.84) | TSHREPHX1TDP1 | |
| SCHEMBL15171908 | 0.88 | TSHR (0.84) | TSHRTDP1 | |
| SCHEMBL1753416 | 0.88 | TSHR (0.71) | TSHREPHX1TDP1ALDH1A1 | |
| SCHEMBL16591356 | 0.87 | TSHR (0.59) | TSHREPHX1 | |
| SCHEMBL13171313 | 0.87 | TSHR (0.68) | TSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170259461-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2017-09-14 | — | — | US | disclosed |
| US-9662809-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20160236379-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2016-08-18 | — | — | US | disclosed |
| US-9340001-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9314548-B2 | Nanostructured surfaces for biomedical/biomaterial applications and processes thereof | LIQUIDIA TECHNOLOGIES, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-20160038418-A1 | NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS | NATIONAL SCIENCE FOUNDATION | 2016-02-11 | — | — | US | disclosed |
| US-20150148903-A1 | Nanostructured Surfaces for Biomedical/Biomaterial Applications and Processes Thereof | LIQUIDIA TECHNOLOGIES, INC. (US) | 2015-05-28 | — | — | US | disclosed |
| US-20150101743-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2015-04-16 | — | — | US | disclosed |
| US-8945441-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140131915-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-8662878-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2014-03-04 | — | — | US | disclosed |
| US-20130202729-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8444899-B2 | Methods and materials for fabricating microfluidic devices | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2013-05-21 | — | — | US | disclosed |
| US-8439666-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2013-05-14 | — | — | US | disclosed |
| US-20120256354-A1 | METHODS AND MATERIALS FOR FABRICATING MICROFLUIDIC DEVICES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-10-11 | — | — | US | disclosed |
| US-20120189728-A1 | METHODS AND MATERIALS FOR FABRICATING LAMINATE NANOMOLDS AND NANOPARTICLES THEREFROM | LIQUIDIA TECHNOLOGIES, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| US-8128393-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2012-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160038418-A1 | NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS | TTN, TAGLN2, TLN1 | TSHR 840/4885EPHX1 827/4885TDP1 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.